Idenix Pharmaceuticals (IDIX)

Add to Watchlists
Create an Alert
5.46 -0.04  -0.73% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD

Idenix Pharmaceuticals News

Edit Sources
Pipeline Update from Idenix - Analyst Blog
Zacks 04/08 16:55 ET

Idenix's nucleotide polymerase inhibitor candidate, IDX21437, showed potent antiviral activity in patients suffering from hepatitis C virus (HCV) infection.

Pipeline Update from Idenix
Yahoo 04/08 15:55 ET

Idenix Pharmaceuticals (IDIX) Jumps: Stock Up 12.4% - Tale of the Tape
Zacks 04/08 08:51 ET

Idenix Pharmaceuticals Inc. was a big mover last session, as its shares rose over 12% on the day.

On The Fly: Closing Wrap
Yahoo 04/07 16:28 ET

Idenix Pharmaceuticals' CEO Presents at Promising Clinical Data Conference (Transcript)
Seeking Alpha 04/07 13:50 ET

Douglas L. Mayers Thanks Teri. I’m happy to provide you an update on the progress of IDX21437. This morning, we are now topline data from our seven-day proof-of-concept study. As a reminder, we initiate ...

Idenix Announces Promising Clinical Data and Continued Progress in Nucleotide Prodrug Development Programs for the Treatment of Hepatitis C
GlobeNewswire 04/07 07:00 ET

CAMBRIDGE, Mass. -- Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced continued progress ...

{{article.title}} {{article.title}}
{{article.source}} {{article.time}}


Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
IDIX 5.46 -0.04 -0.73% 823.39M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.